Tekmira Pharmaceuticals is focused on the discovery, research, and development of RNA interference (RNAi) products with an initial focus on cholesterol management, cancer and Ebola infection.
Address (HQ):
100 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
Canada